Prediction of isolated local recurrence after resection of pancreatic ducta - Evidencio
Prediction of isolated local recurrence after resection of pancreatic ductal adenocarcinoma: a nationwide study

Background: Distinguishing postoperative fibrosis from isolated local recurrence (ILR) after resection of pancreatic ductal adenocarcinoma (PDAC) is challenging. A prognostic model that helps to identify patients at risk of ILR can assist clinicians when evaluating patients’ postoperative imaging. This nationwide study aimed to develop a clinically applicable prognostic model for ILR after PDAC resection.

Methods: An observational cohort study was performed, including all patients who underwent PDAC resection in the Netherlands (2014-2019) (NCT04605237). Based on recurrence location (ILR, systemic, or both), multivariable cause-specific Cox-proportional hazard analysis was conducted to identify predictors for ILR and presented as hazard ratios (HRs) with 95% confidence intervals (CIs). A predictive model was developed using Akaike’s Information Criterion and bootstrapped discrimination and calibration indices were assessed.

Results: Amongst 1194/1693 patients (71%) with recurrence, 252 patients (21%) developed ILR. Independent predictors for ILR were resectability status (borderline versus resectable, HR1.42; 95%CI 1.03-1.96; P=0.03, and locally advanced versus resectable, HR1.11; 95%CI 0.68-1.82; P=0.66), tumor location (head versus body/tail, HR1.50; 95%CI 1.00-2.25; P=0.05), vascular resection (HR1.86; 95%CI 1.41-2.45; P<0.001), perineural invasion (HR1.47; 95%CI 1.01-2.13; P=0.02), number of positive lymph nodes (HR1.04; 95%CI 1.01-1.08; P=0.02), and resection margin status (R1<1mm versus R0≥1mm, HR1.64; 95%CI 1.25-2.14; P<0.001). Moderate performance (concordance index 0.66) with adequate calibration (slope 0.99) was achieved.

Conclusion: This nationwide study identified factors predictive of ILR after PDAC resection. Our prognostic model, available through www.pancreascalculator.com, can be utilized to identify patients with a higher a priori risk of developing ILR, providing important information in patient evaluation and prognostication.

Les auteurs de la recherche: Iris W.J.M. van Goor, Paul C.M. Andel, Hjalmar C. van Santvoort, I. Quintus Molenaar, Martijn P.W. Intven, Lois A. Daamen
Version: 1.24
  • Public
  • Non spécifié
  • {{ modelType }}
  • Détails
  • Valider le algorithme
  • Sauvegarder l'entrée
  • Entrée de la charge
Affichage
Unités

{{ section.title }}

{{ section.description }}

Calculer le résultat

Définir d'autres paramètres pour effectuer le calcul

chance of isolated local recurrence 12 months after resection of pancreatic ductal adenocarcinoma

{{ resultSubheader }}
{{ $t('download_result_availability') }}
{{ chart.title }}
Intervalle de résultats {{ additionalResult.min }} à {{ additionalResult.max }}

Informations conditionnelles

{{ file.classification }}
PRO
Note
Les notes ne sont visibles que dans le téléchargement des résultats et ne sont pas sauvegardées par Evidencio.

Ce algorithme est fourni à des fins d'éducation, de formation et d'information. Il ne doit pas être utilisé pour aider à la prise de décision médicale ou pour fournir des services médicaux ou de diagnostic. Lire l'intégralité de notre disclaimer.

Algorithmes sous-jacents Une partie de
Commentaires
Commentaire
Veuillez saisir un commentaire
Les commentaires sont visibles par tous

Retour d'information sur le algorithme

Pas encore de retour d'information 1 Commentaire {{ model.comments.length }} Commentaires
Sur {{ comment.created_at }} {{ comment.user.username }} un auteur qui n'est plus enregistré a écrit :
{{ comment.content }}
logo

Veuillez vous connecter pour activer les fonctions d'impression d'Evidencio

Pour utiliser les fonctions d'impression d'Evidencio, vous devez être connecté.
Si vous n'avez pas de compte communautaire Evidencio, vous pouvez créer un compte personnel gratuit à:

https://www.evidencio.com/registration

Résultats imprimés - Exemples {{ new Date().toLocaleString() }}


Avantages du compte communautaire Evidencio


With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.


Clause de non-responsabilité : les calculs ne doivent jamais dicter les soins aux patients et ne remplacent pas le jugement d'un professionnel.
Evidencio v3.38 © 2015 - 2025 Evidencio. Tous droits réservés